Skip to Content

Artesunate Approval History

FDA Approved: Yes (First approved May 26, 2020)
Generic name: artesunate
Dosage form: for Injection
Company: Amivas (US), LLC
Treatment for: Malaria

Artesunate for Injection is an antimalarial indicated for the initial treatment of severe malaria in adult and pediatric patients.

Development History and FDA Approval Process for artesunate

DateArticle
May 27, 2020Approval FDA Approves Artesunate for Injection for the Treatment of Severe Malaria
Jul 23, 2019La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118 (Artesunate) for the Treatment of Malaria

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.